{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T01:31:35Z","timestamp":1649122295990},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,10,6]],"date-time":"2009-10-06T00:00:00Z","timestamp":1254787200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1007\/s00417-009-1207-2","type":"journal-article","created":{"date-parts":[[2009,10,5]],"date-time":"2009-10-05T16:59:24Z","timestamp":1254761964000},"page":"231-235","source":"Crossref","is-referenced-by-count":2,"title":["The effect of interferon \u03b2-1a on optic neuritis relapse in patients with multiple sclerosis"],"prefix":"10.1007","volume":"248","author":[{"given":"Yan-Ming","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Chao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fung-Rong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jieh-Ren","family":"Jou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,10,6]]},"reference":[{"key":"1207_CR1","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1212\/WNL.50.3.708","volume":"50","author":"M S\u00f6derstr\u00f6m","year":"1998","unstructured":"S\u00f6derstr\u00f6m M, Jin YP, Hillert J, Link H (1998) Optic neuritis: prognosis for multiple sclerosis from MRI, CSF, and HLA findings. Neurology 50:708\u2013714","journal-title":"Neurology"},{"key":"1207_CR2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1212\/WNL.26.6_Part_2.26","volume":"26","author":"F Ikuta","year":"1976","unstructured":"Ikuta F, Zimmerman HM (1976) Distribution of plaques in seventy autopsy cases of multiple sclerosis in the United States. Neurology 26:26\u201328","journal-title":"Neurology"},{"key":"1207_CR3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/01658108308997307","volume":"3","author":"D Toussaint","year":"1983","unstructured":"Toussaint D, Perier O, Verstappen A, Bervoets S (1983) Clinicopathological study of the visual pathways, eyes, and cerebral hemispheres in 32 cases of disseminated sclerosis. J Clin Neuroophthalmol 3:211\u2013220","journal-title":"J Clin Neuroophthalmol"},{"key":"1207_CR4","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/ana.410270406","volume":"27","author":"M Sandberg-Wollheim","year":"1990","unstructured":"Sandberg-Wollheim M, Bynke H, Cronqvist S, Holt\u00e5s S, Platz P, Ryder LP (1990) A long-term prospective study of optic neuritis: evaluation of risk factors. Ann Neurol 27:386\u2013393","journal-title":"Ann Neurol"},{"key":"1207_CR5","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1212\/WNL.45.2.244","volume":"45","author":"M Rodriquez","year":"1995","unstructured":"Rodriquez M, Siva A, Cross SA, O'Brien PC, Kurland LT (1995) Optic neuritis: a population-based study in Olmsted County, Minnesota. Neurology 45:244\u2013250","journal-title":"Neurology"},{"key":"1207_CR6","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/brain\/121.3.495","volume":"121","author":"JI O\u2019Riordan","year":"1998","unstructured":"O\u2019Riordan JI, Thompson AJ, Kingsley DP, MacManus DG, Kendall BE, Rudge P, McDonald WI, Miller DH (1998) The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. Brain 121:495\u2013503","journal-title":"Brain"},{"key":"1207_CR7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1474-4422(03)00308-9","volume":"2","author":"JI Kira","year":"2003","unstructured":"Kira JI (2003) Multiple sclerosis in the Japanese population. Lancet Neurol 2:117\u2013127","journal-title":"Lancet Neurol"},{"key":"1207_CR8","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0022-510X(76)90214-8","volume":"27","author":"TP Hung","year":"1976","unstructured":"Hung TP, Landsborough D, Hsi MS (1976) Multiple sclerosis amongst Chinese in Taiwan. J Neurol Sci 27:459\u2013484","journal-title":"J Neurol Sci"},{"key":"1207_CR9","first-page":"500","volume":"67","author":"CP Tsai","year":"2004","unstructured":"Tsai CP, Yuan CL, Yu HY, Chen C, Guo YC, Shan DE (2004) Multiple sclerosis in Taiwan. J Chin Med Assoc 67:500\u2013505","journal-title":"J Chin Med Assoc"},{"key":"1207_CR10","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s10384-005-0281-1","volume":"50","author":"YC Lin","year":"2006","unstructured":"Lin YC, Yen MY, Hsu WM, Lee HC, Wang AG (2006) Low conversion rate to multiple sclerosis in idiopathic optic neuritis patients in Taiwan. Jpn J Ophthalmol 50:170\u2013175","journal-title":"Jpn J Ophthalmol"},{"key":"1207_CR11","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1159\/000112858","volume":"29","author":"LC Woung","year":"2007","unstructured":"Woung LC, Lin CH, Tsai CY, Tsai MT, Jou JR, Chou P (2007) Optic neuritis among national health insurance enrollees in Taiwan, 2000\u20132004. Neuroepidemiology 29:250\u2013254","journal-title":"Neuroepidemiology"},{"key":"1207_CR12","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/00041327-200112000-00012","volume":"21","author":"RA Rudick","year":"2001","unstructured":"Rudick RA (2001) Contemporary immunomodulatory therapy for multiple sclerosis. J Neuroophthalmol 21:284\u2013291","journal-title":"J Neuroophthalmol"},{"key":"1207_CR13","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0140-6736(98)10039-9","volume":"352","author":"European Study Group on Interferon Beta-1b in Secondary Progressive MS","year":"1998","unstructured":"European Study Group on Interferon Beta-1b in Secondary Progressive MS (1998) Placebo-controlled multicenter randomized trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. Lancet 352:1491\u20131497","journal-title":"Lancet"},{"key":"1207_CR14","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(98)03334-0","volume":"352","author":"PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group","year":"1998","unstructured":"PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group (1998) Randomized double-blind placebo-controlled study of interferon beta-1a in relapsing\/remitting multiple sclerosis. Lancet 352:1498\u20131504","journal-title":"Lancet"},{"key":"1207_CR15","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ana.10148","volume":"51","author":"RW Beck","year":"2002","unstructured":"Beck RW, Chandler DL, Cole SR, Simon JH, Jacobs LD, Kinkel RP, Selhorst JB, Rose JW, Cooper JA, Rice G, Murray TJ, Sandrock AW (2002) Interferon beta-1a for early multiple sclerosis: CHAMPS trial subgroup analyses. Ann Neurol 51:481\u2013490","journal-title":"Ann Neurol"},{"key":"1207_CR16","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0002-9394(01)01209-0","volume":"132","author":"CHAMPS Study Group","year":"2001","unstructured":"CHAMPS Study Group (2001) Interferon beta-1a for optic neuritis patients at high risk for multiple sclerosis. Am J Ophthalmol 132:463\u2013471","journal-title":"Am J Ophthalmol"},{"key":"1207_CR17","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s10384-006-0359-4","volume":"50","author":"AG Wang","year":"2006","unstructured":"Wang AG, Lin YC, Wang SJ, Tsai CP, Yen MY (2006) Early relapse in multiple sclerosis-associated optic neuritis following the use of interferon b-1a in chinese patients. Jpn J Ophthalmol 50:537\u2013542","journal-title":"Jpn J Ophthalmol"},{"key":"1207_CR18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","volume":"50","author":"WI McDonald","year":"2001","unstructured":"McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121\u2013127","journal-title":"Ann Neurol"},{"key":"1207_CR19","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","volume":"66","author":"DM Wingerchuk","year":"2006","unstructured":"Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66:1485\u20131489","journal-title":"Neurology"},{"key":"1207_CR20","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/archopht.1993.01090060061023","volume":"111","author":"RW Beck","year":"1993","unstructured":"Beck RW, Cleary PA (1993) Optic Neuritis Treatment Trial: one-year follow-up results. Arch Ophthalmol 111:773\u2013775","journal-title":"Arch Ophthalmol"},{"key":"1207_CR21","volume-title":"Optic neuritis and its differential diagnosis","author":"GD Perkin","year":"1979","unstructured":"Perkin GD, Rose FC (1979) Optic neuritis and its differential diagnosis. Oxford Medical Publications, England"},{"key":"1207_CR22","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.ophtha.2007.08.004","volume":"115","author":"Optic Neuritis Study Group","year":"2008","unstructured":"Optic Neuritis Study Group (2008) Visual function 15\u00a0years after optic neuritis: a final follow-up report from the Optic Neuritis Treatment Trial. Ophthalmology 115:1079\u20131082","journal-title":"Ophthalmology"},{"key":"1207_CR23","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199202273260901","volume":"326","author":"RW Beck","year":"1992","unstructured":"Beck RW, Cleary PA, Anderson MM Jr, Keltner JL, Shults WT, Kaufman DI, Buckley EG, Corbett JJ, Kupersmith MJ, Miller NR, Savino PJ, Guy JR, Trobe JD, McCrary JA III, Smith CH, Chrousos GA, Thompson HS, Katz BJ, Brodsky MC, Goodwin JA, Atwell CW (1992) A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. N Engl J Med 326:581\u2013588","journal-title":"N Engl J Med"},{"issue":"7","key":"1207_CR24","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1212\/WNL.52.7.1479","volume":"52","author":"F Sellebjerg","year":"1999","unstructured":"Sellebjerg F, Nielsen HS, Frederiksen JL, Olesen J (1999) A randomized, controlled trial of oral high-dose methylprednisolone in acute optic neuritis. Neurology 52(7):1479\u20131484","journal-title":"Neurology"},{"key":"1207_CR25","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1056\/NEJM199312093292403","volume":"329","author":"RW Beck","year":"1993","unstructured":"Beck RW, Cleary PA, Trobe JD, Kaufman DI, Kupersmith MJ, Paty DW, Brown CH (1993) The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. N Engl J Med 329:1764\u20131769","journal-title":"N Engl J Med"},{"key":"1207_CR26","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM200009283431301","volume":"343","author":"LD Jacobs","year":"2000","unstructured":"Jacobs LD, Beck RW, Simon JH, Kinkel RP, Brownscheidle CM, Murray TJ, Simonian NA, Slasor PJ, Sandrock AW (2000) Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. N Engl J Med 343:898\u2013904","journal-title":"N Engl J Med"},{"key":"1207_CR27","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0140-6736(00)04725-5","volume":"357","author":"G Comi","year":"2001","unstructured":"Comi G, Filippi M, Barkhof F, Durelli L, Edan G, Fernandez O, Hartung H, Seeldrayers P, S\u00f8rensen PS, Rovaris M, Martinelli V, Hommes OR (2001) Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomized study. Lancet 357:1576\u20131582","journal-title":"Lancet"},{"key":"1207_CR28","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.ajo.2005.01.031","volume":"139","author":"AC Arnold","year":"2005","unstructured":"Arnold AC (2005) Evolving Management of Optic Neuritis and Multiple Sclerosis. Am J Ophthalmol 139:1101\u20131108","journal-title":"Am J Ophthalmol"},{"key":"1207_CR29","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1212\/01.wnl.0000237641.33768.8d","volume":"67","author":"L Kappos","year":"2006","unstructured":"Kappos L, Polman CH, Freedman MS, Edan G, Hartung HP, Miller DH, Montalban X, Barkhof F, Bauer L, Jakobs P, Pohl C, Sandbrink R (2006) Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. Neurology 67:1242\u20131249","journal-title":"Neurology"},{"key":"1207_CR30","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1212\/01.WNL.0000151856.10387.E2","volume":"64","author":"T Saida","year":"2005","unstructured":"Saida T, Tashiro K, Itoyama Y, Sato T, Ohashi Y, Zhao Z (2005) Interferon beta-1b Multiple Sclerosis Study Group of Japan. Interferon beta-1b is effective in Japanese RRMS patients: a randomized, multicenter study. Neurology 64:621\u2013630","journal-title":"Neurology"},{"key":"1207_CR31","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00041327-200112000-00001","volume":"21","author":"DD Mikol","year":"2001","unstructured":"Mikol DD (2001) Treat early, but treat hard: Interferon-beta dose makes a difference. J Neuroophthalmol 21:237\u2013239","journal-title":"J Neuroophthalmol"},{"key":"1207_CR32","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","volume":"53","author":"DM Wingerchuk","year":"1999","unstructured":"Wingerchuk DM, Hogancamp WF, O\u2019Brien PC, Weinshenker BG (1999) The clinical course of neuromyelitis optica (Devic\u2019s syndrome). Neurology 53:1107\u20131114","journal-title":"Neurology"},{"key":"1207_CR33","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106\u20132112","journal-title":"Lancet"},{"key":"1207_CR34","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1177\/1352458506070732","volume":"13","author":"C Papeix","year":"2007","unstructured":"Papeix C, Vidal JS, de Seze J, Pierrot-Deseilligny C, Tourbah A, Stankoff B, Lebrun C, Moreau T, Vermersch P, Fontaine B, Lyon-Caen O, Gout O (2007) Immunosuppressive therapy is more effective than interferon in neuromyelitis optica. Mult Scler 13:256\u2013259","journal-title":"Mult Scler"},{"key":"1207_CR35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jns.2006.10.008","volume":"252","author":"Y Warabi","year":"2007","unstructured":"Warabi Y, Matsumoto Y, Hayashi H (2007) Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination. J Neurol Sci 252:57\u201361","journal-title":"J Neurol Sci"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-009-1207-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-009-1207-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-009-1207-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:40:50Z","timestamp":1559072450000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-009-1207-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,6]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["1207"],"URL":"https:\/\/doi.org\/10.1007\/s00417-009-1207-2","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,6]]}}}